|
FAQ No.
|
Question
|
Answers
|
|
1
.
|
What data are collected?
|
ACES collects a high-quality clinical database includes all prior
medical conditions, risk factors, and treatments as well as
functional capacity medications use by name and by dose. It
also captures admission and discharge diagnosis, as well as
all problems, events, procedures and medication changes up
until the time the patient leaves the clinical unit.
|
|
2.
|
How is data quality assured?
|
ACES prints reports that are placed directly on the chart
instead of handwritten notes. It has been rigorously tested to
ensure that these reports accurately reflect the data captured at
the bedside. ACES research data corresponds directly to the
chart, and is of the highest possible quality.
|
|
3.
|
Who use the data?
|
ACES data is intended to be useful to both providers and
health care researchers. For providers, it improves efficiency by
avoiding redundancy. It also provides a means of self
assessment and regulation for quality assurance. The
combined data set is intended as a resource for health care
researchers.
|
|
4.
|
What resources are required for
data analysis, and what are
available?
|
I
nitially, we have focused on developing the ACES software to
provide a sustainable source of high-quality clinical data. Once
this is accomplished, resources can be focused on assisting
providers and researchers data analysis and the dissemination
of results.
|
|
5.
|
How can we ensure adequate
risk stratification for
comparisons between sites?
|
Unlike administrative data sets, ACES will provide the detailed
information needed to avoid "undercorrection" during risk
stratification and adjusting for case mix.
|
|
6.
|
How will ACES protect the
confidentiality of centers?
|
Individual centers have complete access to their own data, but
will not be identified by name to other partners.
|
|
7.
|
How does ACES protect
confidentiality of patients?
|
Personal identifying information is removed before ACES data
are sent to the central database. Patients are identified by an
anonymous identifier, the key for which will remain under the
control of the clinical site.
|